HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...

Hope Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP), announced engagement of BTIG, a leading global financial services ...

HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital therapeutics ...

NRX Pharmaceuticals shares are moving higher on Tuesday after it invested $27 million in its subsidiary HOPE Therapeutics.

NRx Pharmaceuticals (NRXP) announced that it has entered into a binding agreement for a registered direct offering of its common stock with ...

Shares of NRx Pharmaceuticals stock opened at $3.14 on Tuesday. NRx Pharmaceuticals has a 12-month low of $1.10 and a 12-month high of $7.33. The stock has a market cap of $37.96 million, a P/E ...

Investing.com – U.S. stocks were higher after the close on Saturday, as gains in the Basic Materials, Oil & Gas and Industrials sectors led shares higher. At the close in NYSE,... Investing.com ...

Shares of NRx Pharmaceuticals Inc. surged nearly 25% on Tuesday, its best session in almost three weeks, drawing heavy ...

(RTTNews) - HOPE Therapeutics Inc., a subsidiary of NRx Pharmaceuticals Inc. (NRXP), Tuesday announced that it has entered into a Stock Purchase Agreement with Smith & Sauer LLC to secure funding ...

This page features the latest news about the NRX Pharmaceuticals stock. NRXP stock touches 52-week low at $1.59 amid market challenges In a challenging market environment, NRXP Pharmaceuticals Inc ...